Programn Trial Outcomes
61 participants – Average incoming GAD7 score of 18.24
Post-treatment average score of 2.84
Average result – From Chronic to Recovered
Efficacy Evidence
2014 Participation
5100 patients
4% Tech support requests
11% Programme guidance requests
0.6% Voluntary programme terminations
